SecBot SecBot
Insider Buy ·Filed Aug 17, 2026

STLN

Starling Oncology, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed2mo ago SEC0000921895-26-002203
Insider cluster: 1 insiders, $78K total
Actionable Insight • Neutral

The $78K buy is too small to drive a trading signal. Monitor for an earnings or catalyst filing before taking directional exposure. A cluster of >$650K aggregate insider buying would be necessary to reach the 0.1% threshold for a notable signal at this market cap.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
STLN ▲ +0.95% at T+20d
NEUTRAL call +0.95% · α vs SPY +2.93% · entry $6.31 → $6.37
Next anchor: T+60d in 14d
Latest observation: T+48 -1.51% FF3 residual α
Entry = T+0 close
Aug 17, 2026
via day close
T+1d
+1.43%
call +1.43% · α +2.10%
$6.40
settled 2mo ago
T+5d
-2.85%
call -2.85% · α -1.66%
$6.13
settled 2mo ago
T+20d
+0.95%
call +0.95% · α +2.93%
$6.37
settled 6w ago
T+60d
Pending
in 14d

Price Chart

Loading chart...

Executive Summary

A 10% owner of Starling Oncology bought $78K in shares open-market at $6.54, while selling a trivial $624. The net $78K buy is ~0.012% of the $657M market cap, well below the 0.1% proportionality threshold — noise-level dollar amount that does not signal material conviction or new inside information. The filing is a routine, low-impact insider buy with no accompanying corporate event or financial disclosure.

Key Financial Metrics

Direction
buying
Total Value
$78.5K
Insiders
1

Key Facts

  • 10% owner Jorey Chernett purchased 12,000 shares at $6.54 on 2026-08-14, total $78,480
  • Same insider sold 100 shares at $6.24 on 2026-08-13, total $624 (noise)
  • Purchase represents ~0.012% of Starling Oncology's $657M market cap — far below the 0.1% materiality floor
  • No earnings, guidance, or other corporate event accompanies this solitary buy

Financial Impact

Open-market purchase of $78K (0.012% of market cap) is a single round lot for a 10% owner; economically trivial

dilution

Risk Factors

  • Lone 10% owner buy at trivial size — not a reliable indicator of near-term stock movement
  • No accompanying corporate filing (earnings, guidance, M&A) to validate the insider's thesis

Market Snapshot

Exchange
Nasdaq
Sector
Services-Offices & Clinics of Doctors of Medicine

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0000921895-26-002203
3 reports for STLN
Performance horizon
Filters
Rows
Reports for STLN — sortable, filterable
TypeNow
Sep 1, 2026
7w ago
8-K
NEUTRAL ★ 2/10
$6.09 $6.32▲ +3.78%▲ +3.86%$6.59 (+8.21%)
Aug 24, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.30 $6.82▲ +8.25%▲ +8.01%$6.59 (+4.60%)
Aug 17, 2026
10w ago
Insider Buy
NEUTRAL ★ 3/10
$6.31 $6.37▲ +0.95%▲ +2.93%$6.59 (+4.44%)
Showing 3 of 3

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 17, 2026